Exploring the Inhibitory Mechanism of Piceatannol on α-glucosidase Relevant to Diabetes Mellitus
Overview
Affiliations
Due to their association with type 2 diabetes mellitus treatment, α-glucosidase inhibitors have attracted increasing attention of researchers. In this study, we systemically investigated the kinetics and inhibition mechanism of piceatannol on α-glucosidase. Enzyme kinetics analyses showed that piceatannol exhibited strong inhibition on α-glucosidase in a non-competitive manner. Spectroscopy analyses indicated that piceatannol could bind with α-glucosidase to form complexes high affinity. Further, computational molecular dynamics and molecular docking studies validated that the binding of piceatannol was outside the catalytic site of α-glucosidase, which would induce conformational changes of α-glucosidase and block the entrance of substrate, causing declines in α-glucosidase activities. Our results provide useful information not only for the inhibition mechanism of piceatannol against α-glucosidase but also for a novel target site for developing novel α-glucosidase inhibitors as potential therapeutic agents in the treatment of type 2 diabetes mellitus.
Mechanistic study of α-mangostin derivatives as potent α-glucosidase inhibitors.
Sanachai K, Chamni S, Nutho B, Khammuang S, Ratha J, Choowongkomon K Mol Divers. 2025; .
PMID: 39994156 DOI: 10.1007/s11030-025-11141-6.
Zhu X, Zhu J, Xu Z, Liu X Molecules. 2024; 29(12).
PMID: 38930934 PMC: 11206966. DOI: 10.3390/molecules29122869.
Koshak A, Elfaky M, Albadawi D, Abdallah H, Mohamed G, Ibrahim S Int Microbiol. 2024; 28(2):213-225.
PMID: 38767683 DOI: 10.1007/s10123-024-00532-8.
Potential -Glucosidase Inhibitors from the Deep-Sea Sediment-Derived Fungus .
Zhao W, Zeng Y, Chang W, Chen H, Wang H, Dai H Mar Drugs. 2023; 21(3).
PMID: 36976206 PMC: 10056930. DOI: 10.3390/md21030157.
Dos Santos F, Xavier J, da Silva F, Merlin J, Goulart M, Rupasinghe H Molecules. 2022; 27(13).
PMID: 35807309 PMC: 9267955. DOI: 10.3390/molecules27134064.